As previously disclosed, the new subsidiary will be located in Wuxi, a growth area just outside Shanghai. The corporate office will be located at I•Campus, Astra Zeneca’s life science startup hub; this opens opportunities for cooperation with other, similar companies and local organizations with experience of registration of foreign products in China.
Together with the consultancy firm Nordic Match, Calmark has now also prepared an information memorandum (IM) for the planned joint venture. Discussions with interested Chinese investors are underway.
“We are exceedingly happy about the constructive cooperation with Nordic Match”, says Anna Söderlund, CEO of Calmark. “Their solid experience of cross-border transactions between China and the Nordic countries, entrepreneurial mindset and great passion for business are most valuable to us at this stage.”